There are several different types of glaucoma, which refers to a group of eye diseases that can cause permanent vision loss ...

Glaucoma can lead to vision loss with few warning signs. Regular eye exams can catch it early. Key indicators include early ...

The study, conducted in 2022, highlights significant variations in glaucoma prevalence across different demographic groups, ...

Taking an antiviral medication for a year may prevent vision damage associated with shingles that affects the eye, according ...

Spinogenix, Inc., a clinical-stage biopharmaceutical company pioneering first-in-class therapeutics that restore synapses to ...

When it comes to maintaining good eye health, some conditions require more than medication or corrective lenses.

Spinogenix is using small molecule drugs to regenerate synapses in patients with ALS, Alzheimer's disease, schizophrenia, ...

In the age of screens, our eyes are continually exposed to harmful blue light, leading to a rise in vision problems among all ...

Glaucoma Therapeutics MarketThe global glaucoma therapeutics market is projected to be valued at approximately USD 6.9 ...

ALISO VIEJO, Calif.--(BUSINESS WIRE)--Glaukos Corporation (NYSE: GKOS), an ophthalmic pharmaceutical and medical technology company focused on novel therapies for the treatment of glaucoma ...

Ocular Therapeutix's Elutyx drug delivery platform offers sustained long-term effects. See why OCUL stock is a Buy.